Biologicals

Biologicals Market 2026: Why Growth Is Accelerating in U.S. Agriculture

Biologicals are gaining momentum in U.S. agriculture as growers seek efficiency, sustainability, and yield stability in increasingly complex production systems.

Daniel Whitmore
Daniel Whitmore is a U.S.-based journalist covering agricultural markets, biotechnology, crop protection, and seed innovation, with a focus on how these technologies are shaping global food systems.

The biologicals market in U.S. agriculture is entering a new phase of accelerated growth in 2026, driven by rising input costs, sustainability pressures, and the need to improve productivity. According to industry data analyzed by the Agrolatam newsroom, biological products have surpassed $3.5 billion in annual revenues in the U.S. market, consolidating their role as a key component of modern crop systems .

This expansion reflects a structural shift in how growers approach input decisions. Rather than replacing conventional products, biologicals are increasingly integrated into hybrid production strategies aimed at improving yield stability, nutrient efficiency, and resilience under stress conditions.

One of the strongest signals of this growth comes from the retail channel. More than half of agricultural retailers reported increased biological sales during the 2025 season, confirming that demand is not only expanding but also becoming more consistent across different regions and crop systems.

Laboratory testing of biological products: innovation focuses on improving consistency and performance under real field conditions.

Laboratory testing of biological products: innovation focuses on improving consistency and performance under real field conditions.

At the center of this expansion are biostimulants, which continue to dominate the biologicals segment. They accounted for approximately 50% of total biological product sales, far ahead of biofertilizers and biopesticides . Their appeal lies in their ability to enhance plant performance without requiring major changes to existing production systems.

In parallel, biofertilizers are gaining traction, particularly as fertilizer price volatility pushes growers to optimize nutrient use efficiency. Investments from major food companies in regenerative agriculture programs across millions of acres in the U.S. are further accelerating adoption, reinforcing biologicals as a strategic tool rather than an optional input .

The biopesticides segment is also evolving rapidly, supported by increased investment from multinational crop protection companies. New product pipelines, acquisitions, and innovations - including RNAi-based technologies and peptide-based solutions - are expanding the scope of biological crop protection and opening new market opportunities.

Despite this growth, the market still faces structural challenges. Trust remains the biggest barrier, with nearly 40% of industry stakeholders citing concerns about product consistency and field performance . This has led companies to shift their positioning, focusing on data-backed performance, multi-year trials, and integration with conventional systems.

Another key driver of growth is technological innovation. Advances in precision agriculture, digital tools, and targeted applications are enabling more efficient use of biologicals, improving predictability and return on investment. The integration of biological inputs with digital decision-making platforms is expected to be a defining trend in the coming years.

Root system with biological activity: biofertilizers and microorganisms play a key role in nutrient efficiency and plant development.

Root system with biological activity: biofertilizers and microorganisms play a key role in nutrient efficiency and plant development.

At the same time, the competitive landscape is changing. While startups initially led the biologicals segment, major players in crop protection and fertilizers now dominate the market, bringing scale, R&D capabilities, and distribution networks that accelerate adoption .

Looking ahead, industry expectations remain strongly positive. Around 80% of market participants plan to expand their biological product portfolios, signaling continued momentum and long-term confidence in the segment .

The conclusion emerging from the U.S. market is clear: biologicals are no longer a niche innovation but a core component of modern agriculture. Their growth is not driven by replacement, but by their ability to enhance existing systems, reduce risk, and improve efficiency in an increasingly complex production environment.

© AgroLatam. All rights reserved.
Esta nota habla de: